Unknown

Dataset Information

0

CYP3A5*3 and CYP3A4*22 Cluster Polymorphism Effects on LCP-Tac Tacrolimus Exposure: Population Pharmacokinetic Approach.


ABSTRACT: The aim of the study is to develop a population pharmacokinetic (PopPK) model and to investigate the influence of CYP3A5/CYP3A4 and ABCB1 single nucleotide polymorphisms (SNPs) on the Tacrolimus PK parameters after LCP-Tac formulation in stable adult renal transplant patients. The model was developed, using NONMEM v7.5, from full PK profiles from a clinical study (n = 30) and trough concentrations (C0) from patient follow-up (n = 68). The PK profile of the LCP-Tac formulation was best described by a two-compartment model with linear elimination, parameterized in elimination (CL/F) and distributional (CLD/F) clearances and central compartment (Vc/F) and peripheral compartment (Vp/F) distribution volumes. A time-lagged first-order absorption process was characterized using transit compartment models. According to the structural part of the base model, the LCP-Tac showed an absorption profile characterized by two transit compartments and a mean transit time of 3.02 h. Inter-individual variability was associated with CL/F, Vc/F, and Vp/F. Adding inter-occasion variability (IOV) on CL/F caused a statistically significant reduction in the model minimum objective function MOFV (p < 0.001). Genetic polymorphism of CYP3A5 and a cluster of CYP3A4/A5 SNPs statistically significantly influenced Tac CL/F. In conclusion, a PopPK model was successfully developed for LCP-Tac formulation in stable renal transplant patients. CYP3A4/A5 SNPs as a combined cluster including three different phenotypes (high, intermediate, and poor metabolizers) was the most powerful covariate to describe part of the inter-individual variability associated with apparent elimination clearance. Considering this covariate in the initial dose estimation and during the therapeutic drug monitoring (TDM) would probably optimize Tac exposure attainments.

SUBMITTER: Mohammed Ali Z 

PROVIDER: S-EPMC10747255 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

<i>CYP3A5*3</i> and <i>CYP3A4*22</i> Cluster Polymorphism Effects on LCP-Tac Tacrolimus Exposure: Population Pharmacokinetic Approach.

Mohammed Ali Zeyar Z   Meertens Marinda M   Fernández Beatriz B   Fontova Pere P   Vidal-Alabró Anna A   Rigo-Bonnin Raul R   Melilli Edoardo E   Cruzado Josep M JM   Grinyó Josep M JM   Colom Helena H   Lloberas Nuria N  

Pharmaceutics 20231129 12


The aim of the study is to develop a population pharmacokinetic (PopPK) model and to investigate the influence of CYP3A5/CYP3A4 and ABCB1 single nucleotide polymorphisms (SNPs) on the Tacrolimus PK parameters after LCP-Tac formulation in stable adult renal transplant patients. The model was developed, using NONMEM v7.5, from full PK profiles from a clinical study (n = 30) and trough concentrations (C<sub>0</sub>) from patient follow-up (n = 68). The PK profile of the LCP-Tac formulation was best  ...[more]

Similar Datasets

| S-EPMC6265082 | biostudies-literature
| S-EPMC3944116 | biostudies-literature
| S-EPMC5684327 | biostudies-literature
| S-EPMC5642551 | biostudies-literature
| S-EPMC8911319 | biostudies-literature
| S-EPMC8869578 | biostudies-literature
| S-EPMC3620714 | biostudies-literature
| S-EPMC10681408 | biostudies-literature
| S-EPMC10246090 | biostudies-literature
| S-EPMC7997453 | biostudies-literature